Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
6.75
+0.79 (13.26%)
At close: Jun 26, 2026, 4:00 PM EDT
6.79
+0.04 (0.59%)
After-hours: Jun 26, 2026, 7:56 PM EDT
CPIX Employees
Cumberland Pharmaceuticals had 93 employees as of December 31, 2025. The number of employees increased by 2 or 2.20% compared to the previous year.
Employees
93
Change (1Y)
2
Growth (1Y)
2.20%
Revenue / Employee
$450,964
Profits / Employee
-$79,385
Market Cap
101.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Lifecore Biomedical | 382 |
| InterCure | 285 |
| Anika Therapeutics | 235 |
| Journey Medical | 58 |
| Cardiol Therapeutics | 18 |
| Talphera | 12 |
CPIX News
- 1 day ago - Cumberland shares updated FIGHT DMD trial results - TheFly
- 1 day ago - Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference - PRNewsWire
- 5 days ago - RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - PRNewsWire
- 9 days ago - RedHill Biopharma Announces Up To $19.4 Million Private Placement - PRNewsWire
- 18 days ago - RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation - PRNewsWire
- 19 days ago - RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo - PRNewsWire
- 25 days ago - Cumberland announces data from Phase 2a clinical trial of ifetroban - TheFly
- 25 days ago - Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis - PRNewsWire